Application Nr Approved Date Route Status External Links
ANDA078572 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Fluoxetine Delayed-Release Capsules Are Indicated For The Treatment Of: • Acute And Maintenance Treatment Of Major Depressive Disorder [See Clinical Studies ( 14.1 )] . Fluoxetine Delayed-Release Capsules Are Selective Serotonin Reuptake Inhibitor Indicated For: Acute And Maintenance Treatment Of Major Depressive Disorder (Mdd) (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Fluoxetine Hydrochloride FLUOXETINE HYDROCHLORIDE ZINC1530637

Comments